about
Pathophysiology of neurally-mediated syncope.Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.Seroepidemiology of Toxoplasma gondii infection in drivers involved in road traffic accidents in the metropolitan area of Guadalajara, Jalisco, MexicoCerebellar Hemorrhage in a Patient during the Convalescent Phase of Dengue Fever.[Characterisation of factors associated with carotid stenosis in a population at high risk].A Practical Score for Prediction of Outcome After Cerebral Venous ThrombosisOccult hepatitis B in kidney transplants recipients and donors from Western MexicoAdherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosisEvaluation of Cerebral Hemodynamics with Color-Coded Duplex Sonography: Normative Values with Correction of Insonation AnglesGeneral and Abdominal Adiposity and Mortality in Mexico City: Prospective Study of 150 000 AdultsEnfermedad carotídea aterosclerosa y enfermedad de sustancia blanca en sujetos sin historia de infarto cerebral o isquemia cerebral transitoria[Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions]Methods of An Open-Label Proof-Of-Concept Trial of Intravenous Valproic Acid for Severe COVID-19[Myasthenia gravis in adults of institutions pertaining to the Mexican public health system: an analysis of hospital discharges during 2010]
P50
Q33164326-4DD7CFA2-08EB-43E2-8975-E47F8FB417E0Q33829582-2C1C38A0-441F-4D58-9031-22D67632B746Q37367160-29D3C6E4-7D00-43F4-840B-0FE6C825725DQ40186254-D8214B6D-1861-4E71-A0AD-5C0A24DF48FAQ43519819-F27583DF-D548-4891-98CB-5222776121D4Q58580592-FC22DCDD-3F0E-4738-A007-5703EF671706Q91026023-81342E2A-8A9F-494E-81B6-DDA78DB5494CQ92078177-66AA6C0C-743B-47A9-B272-113DC5631327Q92513762-82276E20-0123-4595-B63C-0B5BA50CCA8EQ92569507-203F3585-AB13-41AC-B7A6-6086DD7D6580Q93118829-11F980FA-F68D-48AE-AB4D-7086D8AC681EQ95492592-24329832-5463-4537-B3F7-B0ACD25D0E2CQ95600609-B7B13142-0D2A-4B9F-B9F9-C5261910B022Q95622775-9AF41C3D-4C84-4D09-9492-973FF437149D
P50
description
researcher (ORCID 0000-0002-1142-295X)
@en
name
Erwin Chiquete
@en
type
label
Erwin Chiquete
@en
prefLabel
Erwin Chiquete
@en
P31
P496
0000-0002-1142-295X